FARO Academy

Amyloid-beta peptide oligomerization assays are essential for studying the aggregation of amyloid-beta (Aβ) peptides, which play a critical role in Alzheimer’s disease (AD) pathology. These assays help researchers analyze the formation of toxic Aβ oligomers, which contribute to neurodegeneration. Various techniques, including electrophoresis, ELISA, and fluorescence-based methods, are used to quantify and characterize Aβ oligomers, providing insights into disease mechanisms and potential therapeutic interventions.